The European Commission (EC) has granted approval to Sanofi's Sarclisa in combination with a regimen of bortezomib, ...

Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...

(Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion ...

ESPN NFL insider Adam Schefter discusses NFL training camp battles, rookie standouts, contract disputes and more.

Business leaders on both sides of the Atlantic breathed a sigh of relief that the U.S. and European Union had averted a bruising trade war.

MapLight Therapeutics has raised a $372.5 million series D round, clearing the biotech to chart a course through phase 2 for ...

European companies were on edge on Monday as corporate leaders tried to unpick the real impact of a hard-won U.S. trade deal ...

“HSBC is expected to show a year-on-year drop in full-year profit, to $29.7bn from $32.3bn, so that quantum of change perhaps ...

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative Vaccines" BOSTON ...

By John Lee. The Iraqi Ministry of Health has held high-level discussions with a delegation from French pharmaceutical company Sanofi, aimed at strengthening collaboration on biopharmaceutical ...